Doctors, Genetic Analysis and Licensing - Clinical Research Informer

What Do Patients Have to Say about Gene Therapy Trials? An Upcoming FDA Public Meeting to Hear from Patients and Caregivers

FDA Law Blog

MARCH 13, 2023

In 1999, Jesse Gelsinger, age 18, died four days after doctors at the University of Pennsylvania administered a corrective gene encased in a deactivated adenovirus. The treatment consists of inserting healthy genes into an affected individual’s affected cells and tissues to try and stop or treat the disease.

Gene Therapy

Gene Therapy Gene Trials Clinical Trials

Clinical Research Informer

What Do Patients Have to Say about Gene Therapy Trials? An Upcoming FDA Public Meeting to Hear from Patients and Caregivers

Webinars

Stay Connected